PLRX
NASDAQStockPliant Therapeutics, Inc.
$1.34-0.07 (-4.61%)
52-Week Range
$1.09
$1.87
Key Stats
Market Cap
82.6M
P/E Ratio
—
Dividend Yield
—
Beta
1.28
Volume
578.2K
Avg Volume
504.2K
Performance
1M
+24.78%
3M
+13.71%
6M
-7.84%
YTD
+12.80%
1Y
-8.44%
3Y
-94.88%
5Y
-96.31%
Price Chart
ETF Exposure
PLRX is held by 11 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IWC | iShares Micro-Cap ETF | 0.01% |
| NUSC | Nuveen ESG Small-Cap | 0.01% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About PLRX ETF Exposure
Pliant Therapeutics, Inc. (PLRX) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 82.6M, PLRX is a widely held institutional stock. The stock currently trades at $1.34. Investors can gain exposure to PLRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PLRX, sorted by portfolio weight.